AN OBSERVATIONAL STUDY FOR THE ASSESSMENT OF COMPLIANCE AND PERSISTENCE TO REBIF® THERAPY OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (MS) AND EVALUATION OF POTENTIAL FACTORS INFLUENCING THESE PARAMETERS: